Inhaled immunosuppressants after lung transplantation –real potential to enhance patient outcomes DOI Creative Commons

Gregory I. Snell,

Samantha Ennis,

Bronwyn Levvey

et al.

Expert Review of Respiratory Medicine, Journal Year: 2024, Volume and Issue: unknown, P. 1 - 3

Published: Nov. 27, 2024

Language: Английский

Aerosol inhalation of total ginsenoside repairs acute lung injury and inhibits pulmonary fibrosis through SMAD2 signaling-mediated mechanism DOI

Jiaan Xu,

Li Zhou, Huixin Chen

et al.

Phytomedicine, Journal Year: 2024, Volume and Issue: 133, P. 155871 - 155871

Published: July 14, 2024

Language: Английский

Citations

0
Membrane Permeability and Drug Targeting Potential of Phospholipid‐Based Nanocarriers in Lung Cancer Therapy DOI
Olivia Sen, Poulami Sarkar, Stabak Das

et al.

ChemistrySelect, Journal Year: 2024, Volume and Issue: 9(40)

Published: Oct. 1, 2024

Abstract Lung cancer has become the leading cause of cancer‐related deaths, surpassing all other forms cancer. Among lung cancers, non‐small cell (NSCLC) accounts for approximately 85% cases. The use tobacco, genetic traits, and radiation exposure are amongst major reasons ongoing research in medical field considered efficacy nanocarriers targeting various cells. several biomaterials, lipid‐based have gained special attention due to their excellent compatibility, improved efficacy, encapsulation ability diverse therapeutic agents. Phospholipids naturally occurring amphiphilic moieties found living creatures. presence phospholipids biomembrane aids permeability phospholipid‐based drug carrier. It can also facilitate agents microenvironment without degrading encapsulated drug. be employed develop conjugated vesicular nanoformulation that result prolonged circulatory half‐life controlled release drugs. suitable biomaterials attach a ligand tissue‐specific targeting. Recent researches reported effective chemotherapeutic agents, genes, vaccines through This review focuses on rationality applications therapy.

Language: Английский

Citations

0
Nebulized inhalation drug delivery: clinical applications and advancements in research DOI

Ruyi Yan,

Chang Zou,

Xiaohang Yang

et al.

Journal of Materials Chemistry B, Journal Year: 2024, Volume and Issue: 13(3), P. 821 - 843

Published: Nov. 27, 2024

Nebulized inhalation is a non-invasive drug delivery method with fast onset, low dosage, and fewer side effects. This review covers its principles, devices, clinical applications, future trends in respiratory systemic diseases.

Language: Английский

Citations

0
Inhaled immunosuppressants after lung transplantation –real potential to enhance patient outcomes DOI Creative Commons

Gregory I. Snell,

Samantha Ennis,

Bronwyn Levvey

et al.

Expert Review of Respiratory Medicine, Journal Year: 2024, Volume and Issue: unknown, P. 1 - 3

Published: Nov. 27, 2024

Language: Английский

Citations

0